Co-Authors
This is a "connection" page, showing publications co-authored by Markos Marangos and Charalambos Gogos.
Connection Strength
1.482
-
Elements of Th1/Th2 response and disease severity in COVID-19 patients: A short report. J Med Virol. 2022 01; 94(1):404-406.
Score: 0.241
-
SARS-CoV-2 persistence and non-protective immunity in infected haematological patients. Br J Haematol. 2021 01; 192(2):e51-e54.
Score: 0.229
-
Evidence for increased circulating procoagulant phospholipids in patients with COVID-19 pneumonia and their prognostic role. Clin Chem Lab Med. 2020 10 29; 59(2):e53-e55.
Score: 0.228
-
Remdesivir and tocilizumab: Mix or match. J Med Virol. 2021 01; 93(1):56-58.
Score: 0.222
-
Triple combination therapy with high-dose ampicillin/sulbactam, high-dose tigecycline and colistin in the treatment of ventilator-associated pneumonia caused by pan-drug resistant Acinetobacter baumannii: a case series study. Infez Med. 2019 Mar 01; 27(1):11-16.
Score: 0.203
-
Renal vein thrombosis complicating severe acute pyelonephritis with renal abscesses and associated bacteraemia caused by extended-spectrum beta-lactamase producing Escherichia coli. CEN Case Rep. 2018 May; 7(1):90-93.
Score: 0.187
-
Coronavirus disease 2019 pandemic in Greece, February 26 - May 3, 2020: The first wave. Travel Med Infect Dis. 2021 May-Jun; 41:102051.
Score: 0.059
-
Accurate SARS-CoV-2 seroprevalence surveys require robust multi-antigen assays. Sci Rep. 2021 03 23; 11(1):6614.
Score: 0.058
-
Prognosis of COVID-19: Changes in laboratory parameters. Infez Med. 2020 Jun 01; 28(suppl 1):89-95.
Score: 0.055